Beijing Tong Ren Tang Chinese Medicine rises on solid H1

Beijing Tong Ren Tang Chinese Medicine Co

14/08/2018 08:25

** Shares in Beijing Tong Ren Tang Chinese Medicine Co Ltd
 3613.HK  climb 4.71 pct to their highest since Aug. 3, after it
posts solid first-half results
    ** Stock is set for its best day since May 17
    ** The manufacturer of Chinese medicine says H1 profit rises
19.5 pct to HK$307.5 million and revenue was HK$759.5 million
 urn:newsml:reuters.com:*:nFWN1UZ0PR
    ** As of the previous close, the stock had risen 47.83
percent so far this year
    ** As of 0653 GMT, about 1.25 million shares of the company
have been traded, about 194.1 percent of their 30-day moving
average of 642,290 shares a day
    ** Among the 5 analysts that cover Beijing Tong Ren Tang
Chinese Medicine Co Ltd, the current average rating on the
shares is "buy"; the breakdown of recommendations is 5 "strong
buy" or "buy". The analyst mean price target is HK$17.58


 ((Reuters Messaging: Cheng.Li.thomsonreuters.com@reuters.net))